EULAR 2008 News

Baminercept shows good safety, substantial activity against RA in phase II data reported at EULAR
June 19, 2008
Baminercept alfa, a novel lymphotoxin β-receptor blocker, showed promising safety and efficacy in phase II data reported at EULAR...

Anti-TNF Gene Therapy Appears Safe, May Reduce Pain, Swelling in RA Joints
June 18, 2008
Researchers report that transferring a TNF-antagonist gene into the joint is safe, may reduce pain and swelling in patients with inflammatory arthritis...

At 1 Year, Balloon Kyphoplasty Provides Better Pain, Function Outcomes Than Nonsurgical Care for Osteoporotic Vertebral Fractures
June 17, 2008
After 12 months, patients with acute vertebral compression fractures treated with balloon kyphoplasty had sustained improvements in pain and function compared with those who received nonsurgical care...

Tocilizumab Plus Methotrexate Shows Efficacy for Anti-TNF Refractory Rheumatoid Arthritis
June 17, 2008
Tocilizumab plus methotrexate (MTX) looks to be an effective alternative for rheumatoid arthritis (RA) patients with inadequate response to TNF inhibitors...

Promising Epratuzumab Corticosteroid-Sparing Data Leads to Re-Start of Phase III Studies in Lupus
June 16, 2008
Phase III studies of epratuzumab in systemic lupus erythematosus have resumed after analysis of early data showed steroid-sparing effects...

Belimumab is Back: New Criteria Show Activity in SLE
June 16, 2008
The humanized monoclonal antibody belimumab showed significant activity in the extension of a phase II clinical trial for SLE as measured by new, FDA-approved assessment criteria...

Phase III Data Show Golimumab Efficacy in MTX-Resistant, TNF-Pretreated, Untreated RA
June 16, 2008
Data from the phase III GO-FORWARD and GO-BEFORE studies show that subcutaneous golimumab improves symptoms, function in RA patients after MTX, anti-TNF failure...

• EULAR 2008 Video